Penfluridol
An antipsychotic medication
Penfluridol | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Penfluridol is a long-acting antipsychotic medication primarily used in the treatment of schizophrenia and other chronic psychotic disorders. It belongs to the class of diphenylbutylpiperidine derivatives and is known for its prolonged duration of action, allowing for once-weekly dosing.
Pharmacology[edit | edit source]
Penfluridol acts as a dopamine receptor antagonist, particularly targeting the D2 receptors in the brain. This action helps to alleviate symptoms of psychosis, such as hallucinations and delusions. The drug's long half-life contributes to its extended duration of effect, making it suitable for patients who may have difficulty adhering to daily medication regimens.
Clinical Use[edit | edit source]
Penfluridol is indicated for the management of chronic psychotic disorders, including schizophrenia. Its once-weekly administration is advantageous in improving medication adherence in patients who struggle with daily dosing schedules. The medication is typically administered orally.
Side Effects[edit | edit source]
Common side effects of penfluridol include extrapyramidal symptoms, such as tremors, rigidity, and bradykinesia. Other potential side effects include sedation, weight gain, and anticholinergic effects like dry mouth and constipation. Long-term use may lead to tardive dyskinesia, a condition characterized by involuntary, repetitive body movements.
History[edit | edit source]
Penfluridol was developed in the 1960s and introduced into clinical practice in the 1970s. It was one of the first long-acting oral antipsychotics, providing an alternative to injectable depot antipsychotics. Despite its benefits, the use of penfluridol has declined with the advent of newer atypical antipsychotics that offer improved side effect profiles.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD